IARC has classified RF as “possibly carcinogenic to humans (Group 2B), based on an increased risk for glioma, a malignant type of brain cancer, associated with wireless phone use”. The full findings will be published in 2012.
In an article published in The Lancet Oncology Volume 12, Issue 7, the IARC Working Group stated that: “The Working Group concluded that there is “limited evidence in humans” for the carcinogenicity of RF-EMF…. A few members of the Working Group considered the current evidence in humans “inadequate”…. up to now, reported time trends in incidence rates of glioma have not shown a parallel to temporal trends in mobile phone use”.
Commenting on the findings, Dr Jack Rowley, GSM Association Director for Research and Sustainability said “The IARC classification suggests that a hazard is possible but not likely”.
To understand the potential level of risk, the IARC classification will be part of a wider health risk assessment undertaken by the WHO. Based on this assessment the WHO, governments and public health authorities will decide what further advice, if any, is needed.
The latest WHO fact sheet, published in June 2011, concluded that to date no adverse health effects had been established as being caused by mobile phone use. Read a summary of advice from the WHO.
We recognise that people may be concerned by this classification and we continue to offer advice on reducing exposure.